Portugal vs Switzerland: Previously treated cases tested for RR-/MDR-TB
Portugal
49.0%
in 2024
Switzerland
48.0%
in 2024
Portugal rank
151st
Switzerland rank
153rd
Previously treated cases tested for RR-/MDR-TB over time
- Portugal
- Switzerland
How they compare
Portugal currently reports 49.0% against 48.0% in Switzerland, a difference of 1.0%.
The two have swapped places 7 times across 20 shared years of data; in 2005 it was Switzerland ahead.
Portugal ranks 151st and Switzerland ranks 153rd of 180 countries.
Across the 3 decades both report, Portugal averaged higher in 1 and Switzerland in 2.
Head to head by decade
| Decade | Portugal | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 47.0% | 73.0% | 26.0% | Switzerland |
| 2010s | 51.3% | 64.4% | 13.1% | Switzerland |
| 2020s | 46.0% | 36.6% | 9.4% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Portugal or Switzerland?
- Portugal, at 49.0% against 48.0% in Switzerland as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Portugal and Switzerland?
- 1.0%, with Portugal ahead.
- How many years of comparable data are there for Portugal and Switzerland?
- 20 years are reported by both, from 2005 to 2024.
- How do Portugal and Switzerland rank globally for previously treated cases tested for rr-/mdr-tb?
- Portugal ranks 151st and Switzerland ranks 153rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.